| | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = -$14,736 ) |
| 2024 | 2022 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318 | FULTON | USA | Cancer Biology Research | 000 | 3 | 12/6/2023 | NON-COMPETING CONTINUATION | -$14,736 |
|
| Issue Date FY: 2022 ( Subtotal = $138,260 ) |
| 2022 | 2022 | GEORGIA TECH RESEARCH CORPORATION | 926 DALNEY ST NW | ATLANTA | GA | 30332 | FULTON | USA | Cancer Biology Research | 001 | 3 | 6/15/2022 | NON-COMPETING CONTINUATION | $11,287 |
| 2022 | 2022 | GEORGIA TECH RESEARCH CORPORATION | 926 DALNEY ST NW | ATLANTA | GA | 30332 | FULTON | USA | Cancer Biology Research | 000 | 3 | 2/18/2022 | NON-COMPETING CONTINUATION | $126,973 |
|
| Issue Date FY: 2021 ( Subtotal = $228,534 ) |
| 2021 | 2021 | GEORGIA TECH RESEARCH CORPORATION | 926 DALNEY ST NW | ATLANTA | GA | 30332 | FULTON | USA | Cancer Biology Research | 000 | 2 | 2/25/2021 | NON-COMPETING CONTINUATION | $228,534 |
|
| Issue Date FY: 2020 ( Subtotal = $216,120 ) |
| 2020 | 2020 | GEORGIA TECH RESEARCH CORPORATION | 926 DALNEY ST NW | ATLANTA | GA | 30318 | FULTON | USA | Cancer Biology Research | 000 | 1 | 3/13/2020 | NEW | $216,120 |
|
|